Plasminogen activator in granulocyte-macrophage-CSF transgenic mice
- PMID: 1431138
Plasminogen activator in granulocyte-macrophage-CSF transgenic mice
Abstract
The pattern of expression of urokinase type plasminogen activator (PA) in granulocyte-macrophage-CSF transgenic mice and their normal littermates was studied using RNAse protection assays and a plasminogen-dependent fibrinolytic assay for PA. Urokinase type PA mRNA was expressed at a high level in transgenic peritoneal cells and at a lower level in transgenic eye tissue and spleen, but not in equivalent tissue from the normal mice. Enzymically active PA was detectable in protein extracts from peritoneal cells taken from transgenic mice of less than 8 wk of age (young mice) but not from normals. Paradoxically, extracts from transgenic mice of more than 12 wk of age (old mice) showed little detectable PA activity despite continuing transcription in some mice of this age. The production of PA by peritoneal cells may be responsible for the spontaneous i.p. bleeding which is a feature of the transgenic mice and production in other tissues may help explain the local pathologic changes.
Similar articles
-
Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice.J Immunol. 1991 Nov 1;147(9):2957-63. J Immunol. 1991. PMID: 1655901
-
Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.Cancer Res. 1995 Oct 15;55(20):4681-7. Cancer Res. 1995. PMID: 7553649
-
Regulation of plasminogen activator activity in arthritic joints.J Rheumatol Suppl. 1991 Feb;27:106-9. J Rheumatol Suppl. 1991. PMID: 1902874
-
Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.J Cell Physiol. 1991 Oct;149(1):34-43. doi: 10.1002/jcp.1041490106. J Cell Physiol. 1991. PMID: 1834680
-
Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells.Biochem Biophys Res Commun. 1995 Dec 5;217(1):278-85. doi: 10.1006/bbrc.1995.2775. Biochem Biophys Res Commun. 1995. PMID: 8526923
Cited by
-
A Review of GM-CSF Therapy in Sepsis.Medicine (Baltimore). 2015 Dec;94(50):e2044. doi: 10.1097/MD.0000000000002044. Medicine (Baltimore). 2015. PMID: 26683913 Free PMC article. Review.
-
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.Cytokine. 2015 Oct;75(2):261-71. doi: 10.1016/j.cyto.2015.05.030. Epub 2015 Jun 22. Cytokine. 2015. PMID: 26113402 Free PMC article. Review.
-
The intricate role of growth hormone in metabolism.Front Endocrinol (Lausanne). 2011 Sep 27;2:32. doi: 10.3389/fendo.2011.00032. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22654802 Free PMC article.
-
Transgenic mice in the study of cytokine function.Int J Exp Pathol. 1993 Dec;74(6):525-46. Int J Exp Pathol. 1993. PMID: 7507352 Free PMC article. Review. No abstract available.